Follow
The #PRAC recommended measures to minimise risk of serious #sideeffects with Janus kinase inhibitors for chronic inflammatory disorders.
#chronicillness #SafetyOfMedicines
https://www.ema.europa.eu/en/news/ema-recommends-measures-minimise-risk-serious-side-effects-janus-kinase-inhibitors-chronic
